Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU5F1 | hg38_v1_chr6_-_31170620_31170698 | 0.17 | 3.6e-01 | Click! |
POU2F3 | hg38_v1_chr11_+_120236635_120236642 | 0.05 | 7.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22720615 Show fit | 38.34 |
ENST00000390309.2
|
immunoglobulin lambda variable 3-19 |
|
chr14_-_106593319 Show fit | 30.13 |
ENST00000390627.3
|
immunoglobulin heavy variable 3-53 |
|
chr22_+_22686724 Show fit | 28.88 |
ENST00000390305.2
|
immunoglobulin lambda variable 3-25 |
|
chr14_-_106117159 Show fit | 27.44 |
ENST00000390601.3
|
immunoglobulin heavy variable 3-11 |
|
chr22_+_22409755 Show fit | 27.31 |
ENST00000390299.2
|
immunoglobulin lambda variable 1-40 |
|
chr2_+_89959979 Show fit | 27.22 |
ENST00000453166.2
|
immunoglobulin kappa variable 2D-28 |
|
chr2_-_88947820 Show fit | 25.86 |
ENST00000496168.1
|
immunoglobulin kappa variable 1-5 |
|
chr2_-_89100352 Show fit | 25.41 |
ENST00000479981.1
|
immunoglobulin kappa variable 1-16 |
|
chr14_-_106277039 Show fit | 25.36 |
ENST00000390610.2
|
immunoglobulin heavy variable 1-24 |
|
chr22_+_22357739 Show fit | 25.11 |
ENST00000390294.2
|
immunoglobulin lambda variable 1-47 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 1285.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.9 | 444.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
5.1 | 46.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 40.9 | GO:0002250 | adaptive immune response(GO:0002250) |
0.2 | 19.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 18.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.3 | 18.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 18.1 | GO:0007140 | male meiosis(GO:0007140) |
2.5 | 17.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.6 | 15.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 506.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 396.3 | GO:0005576 | extracellular region(GO:0005576) |
6.7 | 360.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.4 | 299.2 | GO:0072562 | blood microparticle(GO:0072562) |
13.5 | 67.6 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
0.1 | 37.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.4 | 31.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.8 | 15.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 13.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 12.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 1703.1 | GO:0003823 | antigen binding(GO:0003823) |
7.0 | 48.8 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 37.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.4 | 26.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.3 | 17.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 17.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 14.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 13.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 12.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 11.8 | GO:0050700 | CARD domain binding(GO:0050700) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 41.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 29.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 20.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 19.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 16.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 15.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 15.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 12.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 11.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 10.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 41.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 31.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 27.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 16.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 13.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 12.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 10.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 10.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 9.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 9.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |